Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

A paradigm shift in structural biology

The release of protein structure predictions from AlphaFold will increase the number of protein structural models by almost three orders of magnitude. Structural biology and bioinformatics will never be the same, and the need for incisive experimental approaches will be greater than ever. Combining these advances in structure prediction with recent advances in cryo-electron microscopy suggests a new paradigm for structural biology.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Three-dimensional structure predicted by AlphaFold for human BRD4.
Fig. 2: A protein interaction network for BRD4 generated by the String database14.
Fig. 3: The number of entries at resolutions better than 6 Å released by the Electron Microscopy Data Bank per year from 2012 to 2021.

References

  1. Kryshtafovych, A., Schwede, T., Topf, M., Fidelis, K. & Moult, J. Proteins 89, 1607–1617 (2021).

    Article  CAS  Google Scholar 

  2. Jumper, J. et al. Nature 596, 583–589 (2021).

    Article  CAS  Google Scholar 

  3. Baek, M. et al. Science 373, 871–876 (2021).

    Article  CAS  Google Scholar 

  4. Tunyasuvunakool, K. et al. Nature 596, 590–596 (2021).

    Article  CAS  Google Scholar 

  5. Varadi, M. et al. Nucleic Acids Res. https://doi.org/10.1093/nar/gkab1061 (2021).

  6. wwPDB consortium. Nucleic Acids Res. 47, D520–D528 (2019).

    Article  Google Scholar 

  7. Kuhn, T. S. The Structure of Scientific Revolutions (Univ. of Chicago Press, 1962).

  8. Akdel, M. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.09.26.461876 (2021).

  9. Ruff, K. M. & Pappu, R. V. J. Mol. Biol. 433, 167208 (2021).

    Article  CAS  Google Scholar 

  10. Burke, D. F. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.11.08.467664 (2021).

  11. Vamathevan, J. et al. Nat. Rev. Drug Discov. 18, 463–477 (2019).

    Article  CAS  Google Scholar 

  12. Evans, R. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.10.04.463034 (2021).

  13. Humphreys, I. R. et al. Science https://doi.org/10.1126/science.abm4805 (2021).

  14. Szklarczyk, D. et al. Nucleic Acids Res. 49(D1), D605–D612 (2021).

    Article  CAS  Google Scholar 

  15. Walls, A. C. et al. Cell 181, 281–292.e286 (2020).

    Article  CAS  Google Scholar 

  16. Wrapp, D. et al. Science 367, 1260–1263 (2020).

    Article  CAS  Google Scholar 

  17. Mahamid, J. et al. Science 351, 969–972 (2016).

    Article  CAS  Google Scholar 

  18. Marx, V. Nat. Methods 15, 575–578 (2018).

    Article  CAS  Google Scholar 

  19. Wagner, F. R. et al. Nat. Protoc. 15, 2041–2070 (2020).

    Article  CAS  Google Scholar 

  20. Schaffer, M. et al. Nat. Methods 16, 757–762 (2019).

    Article  CAS  Google Scholar 

  21. Narayan, K. & Subramaniam, S. Nat. Methods 12, 1021–1031 (2015).

    Article  CAS  Google Scholar 

  22. Swedlow, J. R. & Collinson, L. Nature 599, 39–40 (2021).

    Article  CAS  Google Scholar 

  23. O’Reilly, F. J. et al. Science 369, 554–557 (2020).

    Article  Google Scholar 

Download references

Acknowledgements

S.S. is supported by awards from a Canada Excellence Research Chair Award, the VGH Foundation, Genome BC and the Tai Hung Fai Charitable Foundation. G.J.K. is supported by EMBL-EBI, with funding from the EMBL member states, as well as by the Wellcome Trust. We thank Z. Wang (EMBL-EBI) for producing Fig. 3 and D. Singer and A. Singh (National Cancer Institute, US National Institutes of Health) for comments.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Sriram Subramaniam or Gerard J. Kleywegt.

Ethics declarations

Competing interests

S.S. is founder and CEO of Gandeeva Therapeutics Inc., a drug discovery company based in Vancouver, BC, Canada.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Subramaniam, S., Kleywegt, G.J. A paradigm shift in structural biology. Nat Methods 19, 20–23 (2022). https://doi.org/10.1038/s41592-021-01361-7

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41592-021-01361-7

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing